Lost Ground: Cancer Screening in the COVID-19 Era
A pandemic-related drop in cancer diagnoses could spell long-term trouble for patients and providers.
Top of the News-dtet
Simplifying At-Home Tests with AI
A new assay uses AI-optimized enzymes to simplify and increase the accuracy of rapid pathogen detection.
Investigating the Cause of the 2022 Severe Acute Hepatitis Outbreak in Children
AAV2 virus detected with metagenomics, TE sequencing, and PCR in non-A–E hepatitis cases from two cohorts in Scotland/the UK and the US.
6 Steps to Data-Driven Transformation
By Nir Kaldero bio
We're now well into the Fourth Industrial Revolution. The First Industrial Revolution was about steam and railroads, the Second about electricity, and the…
One-Fourth of Myriad’s Variants of Unknown Significance Reclassified Over 10 Years
From - Diagnostic Testing & Emerging Technologies
Variant reclassification following hereditary cancer genetic testing is common, according to a study published by…
Multiplex, Point-of-Care Test for STIs Could Offer Public Health Benefits
From - Diagnostic Testing & Emerging Technologies
Point-of-care (POC) testing that could simultaneously identify multiple sexually transmitted infections (STIs) could be a valuable addition to…
Rapid Molecular Testing Saves Hospitals Time, Money Ruling Out TB
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Diagnostics Lagging for Tickborne Infections
From - Diagnostic Testing & Emerging Technologies
The incidence of tickborne infections is on the rise in the United States. Yet, prevention and management of these infections are…
With New FDA Input, Momentum for LDT Regulation Accelerating
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
High-Sensitivity Troponin Test Rules Out Heart Attacks Faster
From - Diagnostic Testing & Emerging Technologies
Use of a high-sensitivity cardiac troponin test (hs-cTnT) may be able to more quickly determine whether emergency department patients are having…
Urinary cfDNA Analysis Valuable for Urinary Tract Infections
From - Diagnostic Testing & Emerging Technologies
Sequencing of urinary cell-free DNA (cfDNA) offers a comprehensive examination of bacterial and viral infections of the urinary tract and could be…
PAMA Unlocks Golden Age for Innovative Diagnostics
By Chance Scott bio
The publication of the 2018 Clinical Laboratory Fee Schedule (CLFS) in January saw a long and heated debate within the lab community come to fruition…
HIV Testing Opportunities Missed For High-Risk Patients
From - Diagnostic Testing & Emerging Technologies
There are many missed opportunities for testing and diagnosis of HIV among high-risk individuals seen in clinical settings…